Publications
University of Turku Medical Biochemistry and Genetics
2011
Aalto, K.; Autio, A.; Kiss, E.A.; Elima, K.; Nymalm, Y.; Veres, T.Z.; Marttila-Ichihara, F.; Elovaara, H.; Saanijoki, T.; Crocker*, P.R.; Maksimow, M.; Bligt, E.; Salmienn, T.A.; Salmi, M.; Roivainen, A. & Jalkanen, S. 2011: Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. – Blood 118:3725–3733. [A1]
Ammar*, A,; Mohammed*, R.A.A.; Salmi, M.; Pepper*, M.; Paish*, E.C.; Ellis*, I.O. & Martin*, S.G. 2011: Lymphatic expression of CLEVER-1 in breast cancer and its relationship with lymph node metastasis. – Anal Cell Pathol 34:67–78. [A1]
Chen*, L.; Qanie*, D.; Jafari*, A.; Taipaleenmäki, H.; Jensen*, C.H.; Säämänen, A-M.; Sanz*, M.L.N.; Laborda*, J.; Abdallah*, B.M. & Kassem*, M. 2011: Delta-like 1/Fetal Antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell diffrentiation via inhibition of the akt kinase-dependent pathway. – J Biol Chem 286(37): 32140–32149. [A1]
Elovaara, H.; Kidron*, H.; Parkash*, V.; Nymalm*, Y.; Bligt*, E.; Ollikka, P.; Smith, J.D.; Pihlavisto, M.; Salmi, M.; Jalkanen, S. & Salminen, T.A. 2011: Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3. – Biochemistry 50:5507–5520. [A1]
Eskildsen*, T.; Taipaleenmäki, H.; Stenvang*, J.; Abdallah*, B.M.; Ditzel*, N.; Nossent*, A.Y.; Bak*, M.; Kauppinen*, S. & Kassem*, M. 2011: MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. – Proc Natl Acad Sci 1–6. [A1]
Farshchian, M.; Kivisaari, A.; Ala-aho, R.; Riihilä, P.; Kallajoki, M.; Grenman, R.; Peltonen, J.; Pihlajaniemi*, T.; Heljasvaara*, R. & Kähäri, V.-M. 2011: Serpin peptidase inhibitor clade a member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma. – Am J Pathol 179(3): 1110–1119. [A1]
Gurtner*, K.; Deuse*, Y.; Bütof, R.; Schaal*, K.; Eicheler*, W.; Oertel*, R.; Grenman, R.; Thames*, H.; Yaromina*, A.; Bauman*, M. & Krause*, M. 2011: Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. – Radiother Oncol 99:323–330. [A1]
Heinonen, J., Taipaleenmäki, H., Roering, P., Takatalo*, M., Harkness*, L., Sandholm, M., Uusitalo-Järvinen, H., Kassem*, M., Kiviranta, R., Laitala-Leinonen, T. & Säämänen, A.-M. 2011: Snorc is a novel cartilage specific small membrane proteoglycan expressed in differentiating and articular chondrocytes. – Osteoarthritis Cartilage 19:1026–1035. [A1]
Jerhammar*,F.; Ceder*, R.; Garvin*, S.; Grenman, R.; Grafström*, R.C. & Roberg*, K. 2011: Fibronectin 1 is a potential biomarker for radioresistance in head and neck squamous cell carcinoma. – Cancer Biol Ther 10(12):1244–1251. [A1]
Koskivirta, I.; Kassiri*, Z.; Rahkonen, O.; Kiviranta, R.; Oudit*, G.Y.; Mckee*, T.D.; Kytö, V.; Jokinen*, E.; Liu*, P.P.; Vuorio, E. & Khokha*, R. 2011: Mice with tissue inhibitor of metalloproteinases 4 (Timp4) deletion succumb to induced myocardial infarction but not to cardiac pressure overload. – J Biol Chem 285 (32):24487–24493. [A1]
Liaskou*, E.; Karikoski, M.; Reynolds*, G.M.; Lalor*, P.F.; Weston*, C.J.; Pullen*, N.; Salmi, M.; Jalkanen, S. & Adams*, D.H. 2011: Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine exidase activity. – Hepatology 53(2):661–672. [A1]
Palani, S.; Maksimow, M.; Miiluniemi, M.; Auvinen, K.; Jalkanen, S. & Salmi, M. 2011: Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages. – Eur J Immunol 41:2052–2063. [A1]
Penttinen, R.P.K. 2011: Cell interaction with bioactive glasses and ceramics. – Bioactive glasses, edited by Heimo O. Ylönen, Woodhead Publishing Limited, s. 53–84.
Pulliainen, A. & Dehio, C. 2011: In situ analysis of tyrosine phosphorylation network by FLIM on cell arrays. F1000.com/7311958. Evaluations.
Pulliainen, A. & Dehio, C. 2011: Translocation of surfae-localized effectors in type III secretion. F1000.com/7778956. Evaluations.
Pulliainen, A. & Dehio, C. 2011: TLR Signaling is required for Salmonella typhimurium virulence. F1000.com/9016956. Evaluations.
Salmi, M. & Jalkanen, S. 2011: Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. – FEBS Letters 585:1543–1550. [A1]
Salo, J.; Loimaranta, V.; Lahdenne*,P.; Viljanen, M.K. & Hytönen, J. 2011: Decorin binding by DbpA and B Borrelia garinii, Borrelia afzelii and Borrelia burgdorfeeri sensu stricto. – JID 204:65–73. [A1]
Shetty*, S.; Weston*, C.J.; Oo*, Y.H.; Westerlund*, N.; Stamataki*, Z.; Youster*, J.; Hubscher*, S.G.; Salmi, M.; Jalkanen, S.; Lalor*, P.F. & Adams*, D.H. 2011: Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. – J Immunol 186:4147–4155. [A1]
Szaumkessel*, M.; Richter*,; Giefing*, M.; Jarmuz*, M.; Kiwerska*, K.; Tönnies*, H.; Grenman, R.; Heidenmann*, S.; Szyfter*, K. & Siebert*, R. 2011: Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma. – Int J Oncol 39(2):505–514. [A1]
Taipaleenmäki, H.; Abdallah*, B.M.; AlDahmash*, A.; Säämänen, A–M. & Kassem*, M. 2011: Wnt signalling mediates the cross-talk between bone marrow derived pre-adipocytic and pre-osteoblastic cell populations. – Exp Cell Res 317(6):745–756 [A1]
Tommila, M.; Stark, C.; Jokilammi, A.; Peltonen, V.; Penttinen, R. & Ekholm, E. 2011: Hemoglobin expression in rat experimental granulation tissue. – J Mol Cell Biol [A1]
Veikkolainen, V.; Vaparanta, K.; Halkilahti, K.; Iljin, K.; Sundvall, M. & Elenius, K. 2011: Function of ERBB4 is determined by alternative splicing. – Cell Cycle 10–16:1–11. [A1]
Ålgars, A.; Karikoski, M.; Yegutkin, G.G.; Stoitzner*, P.; Niemelä, J.; Salmi, M. & Jalkanen, S. 2011: Different role of CD73 in leukocyte trafficking via blood and lymph vessels. – Blood 117(16):4387–4393 [A1]
Veikkolainen, V.; Naillat*, F.; Railo*, A.; Chi*, L.; Manninen*, A.; Hohenstein*, P.; Hastie*, N.; Vainio*, S. & Elenius, K. 2011: ErbB4 modulates tubular cell polarity and lumen diameter during kidney development. – J Am Soc Nephorol 23:1–11. [A1]
Yegutkin, G.G.; Marttila–Ichihara, F.; Karikoski, M.; Niemelä, J.; Laurila, J.P.; Elima, K.; Jalkanen, S. & Salmi, M. 2011: Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. – Eur J Immunol 41:1231–1241. [A1]
2010
*Dias, J.D., *Guse, K., *Nokisalmi, P., *Eriksson, M., *Chen, D-T., *Diaconu, I., *Tenhunen, M., *Liikanen, I., Grenman, R., Savonaus, M., *Pesonen, S., *Cerullo, V. & *Hemminki, A. 2010: Multimodal approach using oncolytic adenovirus , cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures. Eur J Cancer 46:625–635. [C]
Heikkinen, P.T., Nummela, M., Jokilehto, T., Grenman, R., Kähäri, V-M. & Jaakkola, P.M. 2010: Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. – Cencer Res 70:5984–5993. [C]
Hollmén, M. & Elenius, K. 2009: Potential of ErbB4 antibodies for cancer therapy. – Future Oncol 6:37–53. [C]
Iivanainen, E. & Elenius, K. 2010: ErbB targeted and angiogenesis. – Curr Vasc Pharmacol 1:421–31. [C]
Jokilehto, T., Högel, H., Heikkinen, P., Rantanen, K., Elenius, K., Sundström, J. & Jaakkola, P.M. 2010: Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth. – Exp Cell Res 15:1169–1178. [C]
Luukkaa, H., Klemi, P., Hirsimäki, P., Vahlberg, T., Kivisaari, A., Kähäri, V-M. Grenman, R. 2010: Matrix metalloproteinase (MMP)-7 in salivary gland cancer. – Acta Oncol 49:85–90. [C]
Luukkaa, H., Klemi, P., Leivo, I., *Mäkitie, A.A., *Irish, J., *Gilbert, R., *Perez-Ordonez, B., Hirsimäki, P., Vahlberg, T., Kivisaari, A., Kähäri, V-M. & Grenman, R. 2010: Expression of matrix metalloproteinase -1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer. – Head Neck 32:1019–1027. [C]
*Pera, N.P., Kouki, A., Haataja, S., *Branderhorst, H.M., *Liskamp, R.M.J., *Visser, G.M., Finne, J. & *Pieters, R.J. 2010: Detection of pathogenic Streptococcus suis bacteria using magnetic glycoparticles. – Org Biomol Chem 8:2425–2429. [C]
Pinta, E., Duda, K.A., Hanuszkiewicz, A., Salminen, T.A., Bengoechea, J.A., Hyytiäinen, H., Lindner, B., Radziejewska-Lebrecht, J., Holst, O. & Skurnik, M. 2010: Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core. – J Biol Chem 285:28333–28342. [C]
Sainio, A., Jokela, T., Tammi, M.I. & Järveläinen, H. 2010: Hyperglycemic conditions modulate connective tissue reorganization by human vascular smooth muscle cells through stimulation of hyaluronan synthesis. – Glycobiology 20:1117–1126. [C]
Stokes, A., Joutsa, J., Ala-aho, R., Pitchers, M., Pennington, C.J., Martin, C., Premachandra, D.J., Okada, Y., Peltonen, J., Grenman, R., James, H.A., Edwards, D.R. & Kähäri, V.-M. 2010: Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.Clin Cancer Res. 16:2022–2035. [C]
Sundvall, M., Karrila, A., Nordberg, J., Grenman, R. & Elenius, K. 2010: EGFR tarketingdrugs in the treatment of head and neck squamous cell carcinoma. – Expert Opin Emerg Drugs, Apr 23 15:1–17. [C]
Wilson, T., Stark, C., Holmbom, J., Rosling, A., Kuusilehto, A., Tirri, T., Penttinen, R. & Ekholm, E. 2010: Fate of bone marrow-derived stromal cells after intraperitoneal infusion or implantation into femoral bone defects in the host animal. – J Tissue Engineering 1–9 [C]
2009
*Al Sheikh Ali, M., *Gunduz, M., *Gunduz, E., *Tamamura, R., *Beder, L., *Tominaga, S., *Onoda, T., *Yamanaka, N., Grenman, R., *Shimizu, K., *Nagai, N. & *Nagatsuka, H. 2009: Lack of B-RAF mutations in head and neck squamous cell carcinoma. – Folia Biol-Prague 54:157–161.[C]
*Al Sheikh Ali, M., *Gunduz, M., *Nagatsuka, H., *Gunduz, E., *Cengiz, B., *Fukushima, K., *Beder, L.B., *Demircan, K., *Fujii, M., *Yamanaka, N., *Shimizu, K., Grenman, R. & *Nagai, N. 2009: Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. – Cancer Sci 99:1589–1594. [C]
*Ansell, A., *Farnebo, L., Grenman, R., *Roberg, K. & *Thunell, L.K. 2009: Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer. – Oral Oncol 45:23–29. [C]
*Beder, L.B., *G unduz, M., *Hotomi, M., *Fujihara, K., *Shimada, J., *Tamura, S., *Gunduz, E., *Fukushima, K., *Yaykasli, K., Grenman, R., *Shimizu, K. & *Yamanaka, N. 2009: T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas. – Cancer Sci 5:873–880. [C]
*Giefing, M., *Martin-Subero, J.I., *Kiwerska, K., *Jarmuz, M., Grenman, R., *Siebert, R. & *Szyfter, K. 2009: Characterization of homozygous deletions in laryngeal squamous cell carcinoma cell lines. – Cancer Genet Cytogen 184; 38–43. [C]
*Hoffman, T.K., *Sonkoly, E., *Huser, U., *van Lierop, A., *Whiteside, T.L., *Klussmann, J.P., *Hafner, D., *Schuler, P., *Friebe-Hoffmann, U., *Scheckenbach, K., Erjala, K., Grenman, R., *Schipper, J., *Bier, H. & *Balz, V. 2009: Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. – Oral Oncol 44:1100–1109. [C]
Hollmén, M., Määttä, J.A., *Bald, L., *Sliwkowski, M.X. & Elenius, K. 2009: Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms. – Oncogene 28:1309-1319.[C]
Iivanainen, E., *Lauttia, S., Zhang, N., Tvorogov, D., Kulmala, J., Grenman, R., *Salven, P. & Elenius, K. 2009: The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels. – Microvasc Res [C]
Järveläinen, H., Sainio, A., Koulu, M., *Wight, T.N. & Penttinen, R. 2009: Extracellular atrix molecules: Potential targets in pharmacotherapy. – Pharmacol Rev 61:198–223. [C]
*Järvinen, K., *Autio, R., *Kilpinen, S., *Saarela, M., *Leivo, I., Grenman, R., *Mäkitie, A.A. & *Monni, O. 2009: High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. – Gene Chromosome Canc 47:500–509. [C]
*Koski, T.A., *Lehtonen, H.J., *Kowan, J.J., *Ninomiya, S., *Joosse, S.A., *Vahteristo, P., *Kiuru, M., *Karhu, A., *Sammalkorpi, H., *Vanharanta, S., *Lehtonen, R., *Edgren, H., *Nederlof, P.M., Hietala, M., *Aittomäki, K., *Herva, R., *Knuutila, S., *Aaltonen, L.A. & *Launonen, V. 2009: Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer. – Genes, Chromosomes & Cancer 48:544–551. [C]
Kurppa, K. & Elenius, K. 2009: Mutated ERBB4: a novel drug target in metastatic melanoma? – Pigment Cell Melanoma Res 1–2.
Loimaranta, V., Hytönen, J., Pulliainen, A.T.,*Sharma, A., Tenovuo, J., *Strömberg, N. & Finne, J. 2009: Leucine-rich repeats of bacterial surface proteins serve as common pattern recognition motifs of human scavenger receptor gp340. – J Biol Chem 284:18614–18623. [C]
Morko, J., Kiviranta, R., Mulari, M.T.K., Ivaska, K.K., Väänänen, H.K., Vuorio, E. & Laitala-Leinonen, T. 2009: Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro. – Bone 44:717-728. [C]
*Muraoka-Cook, R.S., *Sandahl, M.A., *Strunk, K.E., *Miraglia, L.C., *Husted, C., *Hunter, D.M., Elenius, K., *Chodosh, L.A. and *Earp, H.S. 2009: ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vitro. –Mol Cell Biol 29:4935–4948. [C]
Määttä, J.A., Olli, K., Henttinen, T., Tuittila, M.T., Elenius, K. & Salmivirta, M. 2009: Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor. – BMC Cell Biol 10:5. [C]
Nyrhinen, T., Hietala, M., Puukka, P. & Leino-Kilpi, H. 2009: Are patient rights to information and self-determination in diagnostic genetic testing upheld? A comparison of patients’and providers’ perceptions. – J Genet Councel 18:72–81. [C]
Peltola, K., Hollmen, M., Maula, S-M., Rainio, E., Ristimäki, R., Luukkaa, M., Sandholm, J., Sundvall, M., Elenius, K., Koskinen, P.J., Grenman, R. & Jalkanen, S. 2009: Pim-1 kinase expression predicts radiation esponse in squamouscellular carcinoma of head and neck and is under the control of epidermal growth factor receptor 1,2 – Neoplasia 7:629-636. [C]
Penttinen, M., Koillinen, H., Niinikosk, H., *Mäkitie, O. & Hietala, M. 2009: Genitopatellar syndrome in an adolescent female with severe osteoporosis and endocrine abnormalities. – Am J Med Genet 149:451–455. [C]
Pinta, E., *Duda, K.A., *Hanuszkiewicz, A., *Kaczynski, Z., *Lindner, B., *Miller, W.L., Hyytiäinen, H., *Vogel, C., *Borowski, S., *Kasperkiewicz, K., *Lam, J.S., *Radziejewska-Lebrecht, J., Skurnik, M. & *Hlst, O. 2009: Identification and role of a 6-deoxy-4-keto-hexosamine in the lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3. –Chem Eur J 15:9747-9754. [C]
*Tikka, S., Mykkänen, K., *Ruchoux, M-M., *Bergholm, R., Junna, M., *Pöyhönen, M., *Yki-Järvinen, H., *Joutel, A., *Viitanen, M., *Baumann, M. & Kalimo, H. 2009: Congruence between NOTCH3 mutations and GOM in 131 CADASIL patients. – Brain 132:933-939. [C]
Tommila, M., Jokilammi, A., Terho, P., Wilson, T., Penttinen, R. & Ekholm, E. 2009: Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue. – J R Soc Interface [C]
Toriseva, M. & Kähäri, V.-M. 2009: Proteinases in cutaneous wound healing. – Cell Mol Life Sci 66:203–224. [C]
Tvorogov D., Sundvall, M., Kurppa, K., Hollmén, M., Repo, S., Johnson, M. & Elenius, K. 2009: Somatic mutations of ErbB4. Selective loss-of-function phenotype affecting signal transduction pathways in cancer. – J Biol Chem 284:5582-5591. [C]
Wilson, T., Viitala, R., Puska, M., *Jalonen, H., Penttinen, R. & Jokinen, M. 2009: The release and bioactivity of lysozyme from selected sol-gel derivered SiO2 matrices. – Key Engineering Materials Vols. 396:547-550.[C]
Wilson, T., Viitala, R., Puska, M., Jokinen, M. & Penttinen, R. 2009: Macrophge induced effect of particulate silica on rat mesenchymal stem cells in vitro. – Key Engineering Materials Vols. 396:123-126. [C]
Zhang, N., Erjala, K., Kulmala, J., *Qiu, X., Sundvall, M., Elenius, K. & Grenman, R. 2009: Concurrent cetuximab, cisplatin and radiation for squamous cell carcinoma of the head and neck in vitro. – Radiother Oncol [C]
2008
*Branderhorst, H.M., *Kooij, R., Salminen, A., *Jongeneel, L., *Arnusch, C., *Liskamp, R.M.J., Finne, J. & *Pieters, R.J. 2008: Synthesis of multivalent Streptococcus suis adhesion inhibitors by enxymatic cleavage of polygalacturonic acid and ´click`conjugation. – Org Biomol Chem 6:1425–1434. [C]
*Chen, H., *Ma, Y., *Yang, J., *O´Brien, C.J., *Lee, S.L., *Mazurkiewicz, J.E., Haataja, S., *Yan, J-H., *Gao, G.F. & *Zhang, J-R. 2008: Genetic Requirement for pneumococcal ear infection. – PLos ONE 3 [C]
Haukioja, A., Loimaranta, V. & Tenovuo, J. 2008: Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. – Oral Microbiol Immun 23:336–343. [C]
Paatero, I. & Elenius, K. 2008: ErbB4 and its isoforms: Patentable drug targets ?Recent Patents on DNA & Gene Sequences 2:27–33. [C]
Penttinen, R. & Grönroos, J.M. 2008: Mesh repair of common abdominal hernias: a review on experimental and clinical studies. – Hernia 12:337–344. [C]
Pulliainen, A.T., Hytönen, J., Haataja, S. & Finne, J. 2008: Deficiency of the Rgg regulator promotes H2O2 resistance AhpCF-mediated H2O2 decomposition and virulence in Streptococcus pyogenes. – J Bacteriol 190:3225–3235. [C]
Salomäki, H.H., Sainio, A.O., Söderström, M., Pakkanen, S., Laine, J. & Järveläinen H.T. 2008: Differential expression of decorin by human malignant and benign vascular tumors. – J Histochem Cytochem 56:639–646. [C]
Sundvall, M., Iljin, K., *Kilpinen, S., Sara, H., *Kallioniemi, O-P. & Elenius, K. 2008: Role of ErbB4 in breast cancer. – J Mammary Gland Biol Neoplasia [C]
Sundvall, M., Korhonen, A., Paatero, I., *Gaudio, E., *Melino, G., *Croce, C.M., *Aqeilan, R.I. & Elenius, K. 2008: Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. – Proc Natl Acad Sci USA 105:4162–4167. [C]
Suomi, S., Taipaleenmäki, H., Seppänen, A., *Ripatti, T., Väänänen, K., Hentunen, T., Säämänen, A.-M. & Laitala-Leinonen, T. 2008: MicroRNAs regulate osteogenesis and chondrogenesis of mouse bone marrow stromal cells. – Gene Reg and Systems Biol 2:177–19. [C]
Säämänen, A.-M., *Vasara, A., *Lammi, M.J. & Kiviranta, I. 2008: Rustovamman kirurginen korjaaminen solusiirteiden ja biomateriaalien avulla. – Duodecim 124:1910-1918. [C]
Taipaleenmäki, H., Suomi, S., Hentunen, T., Laitala-Leinonen, T. & Säämänen, A-M. 2008: Impact of stromal cell composition on BMP-induced chondrogenic differentiation of mouse bone marrow derived mesenchumal cells. – Exp Cell Res 314:2400–2410. [C]
Tommila, M., Jokinen, J., Wilson, T., Forsback, A-P., Saukko, P., Penttinen, R. & Ekholm, E. 2008: Bioactive glass-derived hydroxyapatite-coating promotes granulation tissue growth in subcutaneous cellulose implants in rats. – Acta Biomater 4:354–361. [C]
*Zelmer, A., *Bowen, M., Jokilammi, A., Finne, J., *Luzio, J.P. & *Taylor, P.W. 2008: Differential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1. – Microbiol 154:2522–2532. [C]
2007
*Aaltonen, V., *Koivunen, J., Laato, M. & Peltonen, J. 2007: PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells. – Cancer Lett 253:97–107. [C]
*Aqeilan, R., *Donati, V., *Gaudio, E., *Nicoloso, M., Sundvall, M., Korhonen, A., *Lundin, J., *Isola, J., *Sudol, M., *Joensuu, H., *Croce, C. & Elenius, K. 2007: Association of Wwox with ErbB4 in breast cancer. – Cancer Res 67:9330–9336. [C]
Borgenström, M., Wärri, A., Hiilesvuo, M., Käkönen, R., *Käkönen, S., *Nissinen, L., *Pihlavisto, M., *Marjamäki, A., *Vlodavsky, I., *Naggi, A., *Torri, G., *Casi, B., Veromaa, T., Salmivirta, M. & Elenius, K. 2007: O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis. – Semin Thromb Hemost 33:547–556. [C]
Erjala, K., Raitanen, M., Kulmala, J. & Grenman, R. 2007: Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines. – J Cancer Res Clin Oncol 133:169-176. [C]
Erjala, K., Zhang, N., Sundvall, M., Kulmala, J., Elenius, K. & Grenman, R. 2007: Concomitant chemoirradiation with vinorelbine and gefitinib induced additive effect in head and neck squamous cell carcinoma cell line in vitro. – Radiother Oncol 85:138–145. [C]
*Hilska, M., Roberts, P.J., Collan, Y.U., Laine, V.J.O., *Kössi, J., Hirsimäki, P., Rahkonen, O. & Laato, M. 2007: Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. – Int J Cancer 121:714–723. [C]
*Ihalainen, S., *Soliymani, R., Iivanainen, E., *Mykkänen, K., Sainio, A., *Pöyhönen, M., Elenius, K., Järveläinen, H., *Viitanen, M. Kalimo, H. & *Baumann, M. 2007: Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient. – Mod Med 13:1–10. [C]
Iivanainen, E., Paatero, I., Heikkinen, S-M., Junttila, T., *Cao, R., *Klint, P., Jaakkola, P., *Cao, Y. & Elenius, K. 2007: Intra- and extracellular signaling by endothelial neuregulin-1. – Exp Cell Res 313:2896–2909. [C]
Jakobsson, E., Jokilammi, A., Aalto, J., Ollikka, P., Lehtonen, J., Hirvonen, H. & Finne, J. 2007: Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages. – Biochem J 405:465–472. [C]
Jokilammi, A., Korja, M., Jakobsson, E. & Finne, J. 2007: Generation of lectins from enzymes: Use of inactive endosialidase for polysialic acid detection. – In: Analytical Technologies, C.L. Nilsson (ed.) Elsevier B.V., pp. 385–395. [D]
Junttila, M.R., Ala-aho, R., Jokilehto, T., Peltonen, J., Kallajoki, M., Grenman, R., Jaakkola, P., Westermarck, J. & Kähäri, V-M. 2007: p38 and p38 mitogen-activated protein kinase isoforms regulate invasion and gowth of head and neck squamous carcinoma cells. – Oncogene 26:5267–5279. [C]
Junttila, M.R., Puustinen, P., Niemelä, M., Ahola, R., *Arnold, H., *Böttzauw, T., Ala-aho, R., *Nielsen, C., Ivaska, J., *Taya, Y., *Lu, S-L., *Lin, S., *Chan, E., *Wang, X-J., Grenman, R., *Kast, J., *Kallunki, T., *Sears, R., Kähäri, V-M. & Westermarck, J. 2007: CIP2A inhibits PP2A in human malignancies. – Cell 130:51–62 [C].
*Kajanne, R., *Miettinen, P., *Mehlem, A., Leivonen, S-K., *Birres, M., *Foschi, M., Kähäri, V-M. & *Leppä, S. 2007: EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. – J Cell Physiol 212:489–497. [C]
Leivonen, S-K. & Kähäri, V.-M. 2007: Transforming growth factor-β signaling in cancer invasion and metastasis. – Int J Cancer 121:2119–2124. [C]
Pulliainen, A., *Enninga, J., *Fernández-Arenas, E. & *Griffiths, G. 2007: A course with a difference. Fighting infectious diseases with technology and knowledge-transfer. – EMBO rep. 8:117–120. []
*Roberg, K., *Jonsson, A-C., Grenamn, R. & *Norberg-Spaak, L. 2007: Radiotherapy response in oral squamous carcinoma cell lines: Evaluation of apoptotic proteins as prognostic factors. – Head & Neck 29: 325–334. [C]
Salminen, A., Loimaranta, V., *Joosten, J.A., *Khan A.S., *Hacker, J., *Pieters, R.J. & Finne, J. 2007: Inhibition of P-fimbriated Escherichia coli adhesion by multivalent galabiose derivatives studied by a live-bacteria application of surface plasmon resonance. – J Antimicrob Chemoth 60:495–501. [C]
Salminen-Mankonen, H., Morko, J. & Vuorio, E. 2007: Role of cathepsin K in normal joints and in the development of arthritis. – Curr Drug Targets 8:315–323. [D]
*Sundelin, K., *Roberg, K., Grenman, R. & *Håkansson, L. 2007: Effects of cisplatin, α-interferon, and 13-cis retinoic acid on the expression of Fas (CD95), intercellular adhesion molecule-I (ICAM-I), and epidermal growth factor receptor (EGFR) in oral cancer cell lines. – J Oral Pathol Med 36:177–183. [C]
Sundvall, M., Peri, L., Määttä, J., Tvorogov, D., Paatero, I., Savisalo, M., *Silvennoinen, O., *Yarden, Y. & Elenius, K. 2007: Differential nuclear localization and kinase activity of alternative ErB4 intracellular domains. – Oncogene 1–10. [C]
Säämänen, A-M., Hyttinen, M. & Vuorio, E. 2007:Analysis of arthritic lesions in the Del1 mouse: a model for osteoarthritis. Methods Mol Med 136:283–302.[D]
Toriseva, M., Ala-aho, R.,* Karvinen, J., *Baker, A., Marjomäki, V., Heino, J. & Kähäri, V-M. 2007: Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. – J Invest Dermatol 127:49–59. [C]
*Yaromina, A., *Krause, M., *Thames, H., *Rosner, A., *Krause, M., *Hessel, F., Grenamn, R., *Zips, D. & *Baumann, M. 2007: Pre treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. – Radiother Oncol 83:304–310. [C]
2006
*Aaltonen, V., *Koivunen, J., Laato, M. & *Peltonen, J. 2006: Heterogeneity of cellular proliferation within transitional cell carcinoma: Correlation of protein kinase C alpha/betaI expression and activity. ? J Histochem Cytochem 54:795?806. [C]
*Bhboudi, A., *Enlund, F., *Winnes, M., *Andrén, Y., *Nordkvist, A., *Leivo, I., *Flaberg, E., *Szekely, L., *Mäkitie, A., Grenman, R., *Mark, J. & *Stenman, G. 2006: Molecular classification of mucoepidermoid carcinomas ? Prognostic significance of the MECT1-MAML2 fusion oncogene. ? Genes, Chromosomes and Cancer 45:470?481. [C]
Elenius, K. 2006: Epidermaalisen kasvutekijän reseptorin estäjät syövän hoidossa. ? Duodecim 122:1331-1338.
Erjala, K., Sundvall, M., Junttila, T.T., Zhang, N., Savisalo, M., Mali, P., Kulmala, J., Pulkkinen, J., Grenman, R. & Elenius, K. 2006: Signaling via ErbB2 and ErbB3 associates with resistance and Epidermal Growth Factor Receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells. ? Clin Cancer Res 12:4103?4111. [C]
Hytönen, J., Haataja, S. & Finne, J. 2006: Use of flow cytometry for the adhesion analysis of Streptococcus pyogenes mutant strains to epithelial cells: investigation of the possible role of surface pullulanase and cysteine protease, and the transcriptional regulator Rgg. ? BMC Microbiol 6:18. [C]
Jokilehto, T., Rantanen, K., Luukkaa, M., Heikkinen, P., Grenman, R., Minn, H., Kronqvist, P. & Jaakkola, P. 2006: Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. ? Clin Cancer Res 12:1080?1087.
*Järvellä, S., *Helin, H., *Haapasalo, J., *Järvellä, T., Junttila, T.T., Elenius, K., *Tanner, M., *Haapasalo, H. & *Isola, J. 2006: Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival. ? Neuropath Appl Neuro 32:441?450. [C]
Koskivirta, I., *Rahkonen, O., *Mäyränpää, M., Pakkanen, S., Husheem, M., Sainio, A., Hakovirta, H., Laine, J., *Jokinen, E., Vuorio, E., *Kovanen, P. & Järveläinen, H. 2006: Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. ? Histochem Cell Biol 126:335?342. [C]
Leivonen, S-K., Ala-aho, R., *Koli, K., Grenman, R. & Kähäri, V-M. 2006: Activation of smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. ? Oncogene 25:2588?2600. [C]
Luukkaa, M., Vihinen, P., Kronqvist, P., Vahlberg, T., Pyrhönen, S., Kähäri, V-M. & Grenman, R. 2006: Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. ? Head Neck 28:225?234. [C]
*Marjamaa, J., *Tulamo, R., *Abo-Ramadan, U., *Hakovirta, H., *Frösen, J., *Rahkonen, O., *Niemelä, M., *Bornstein, P., Penttinen, R. & *Kangasniemi, M. 2006: Mice with a deletion in the first intron of the Col1a1 gene develop dissection and rupture of aorta in the absence of aneurysms: high-resolution magnetic resonance imaging, at 4.7 T, of the aorta and cerebral arteries. ? Magn Reson Med 55:592?597. [C]
Määttä, J.A., Sundvall, M., Junttila, T.T., Peri, L., Laine, V.J.O., *Isola, J., *Egeblad, M. & Elenius, K. 2006: Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. ? Mol Biol Cell 17:67?79. [C]
*Shinozaki, K., Suominen, E., *Carrick, F., *Sauter, B., Kähäri, V-M., *Lieber, A., *Woo, SLC. & Savontaus, M. 2006: Efficient infection of tumor endothelial cells by a capsin-modified adenovirus. ? Gene Ther 13:52?59. [C]
Wilson, T., Parikka, V., Holmbom, J., Ylänen, H. & Penttinen, R. 2006: Intact surface of bioactive glass S53P4 is resistant to osteoclastic activity. ? J Biomed Mater Res 77A:67?74. [C]
Vähä-Koskela, M., Kallio, J., Jansson, L., Heikkilä, J., Zakhartchenko, A., Kallajoki, M., Kähäri, V-M., Hinkkanen, A. 2006: Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice. ? Cancer Res 66:7185?7194. [C]
Välimäki, V-V., Moritz, N., Yrjans, J., Vuorio, E. & Aro, H. 2006: Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. ? Bone 38:432?443. [C]